In conclusion, the TAC/MSC complex can participate in the regulation of lipid metabolism by increasing the expression of lipid-mobilizing enzymes ATGL and HSL in the white fat of T2DM mice and down-regulating the expression of fatty acid synthase FAS and SREBP-1c in mouse liver. Here, FASN is linked to type 2 diabetes mellitus.